BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1251 related articles for article (PubMed ID: 19801221)

  • 1. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer: role of SPECT and PET in imaging bone metastases.
    Ben-Haim S; Israel O
    Semin Nucl Med; 2009 Nov; 39(6):408-15. PubMed ID: 19801220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
    Sahin E; Zincirkeser S; Akcan AB; Elboga U
    J BUON; 2014; 19(1):291-6. PubMed ID: 24659678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I; Sivrikoz MC; Entok E; Vardareli E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of bone metastases in prostate cancer: an update.
    Langsteger W; Haim S; Knauer M; Waldenberger P; Emmanuel K; Loidl W; Wolf I; Beheshti M
    Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):447-58. PubMed ID: 23069924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.
    Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H
    J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
    Schirrmeister H; Guhlmann A; Elsner K; Kotzerke J; Glatting G; Rentschler M; Neumaier B; Träger H; Nüssle K; Reske SN
    J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
    Gerety EL; Lawrence EM; Wason J; Yan H; Hilborne S; Buscombe J; Cheow HK; Shaw AS; Bird N; Fife K; Heard S; Lomas DJ; Matakidou A; Soloviev D; Eisen T; Gallagher FA
    Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
    Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
    J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
    Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O
    Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of PET/CT in the evaluation of skeletal metastases.
    Kannivelu A; Loke KS; Kok TY; Osmany SY; Ali SZ; Suat-Jin L; Ng DC
    Semin Musculoskelet Radiol; 2014 Apr; 18(2):149-65. PubMed ID: 24715447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
    Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
    Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
    J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
    De Luca S; Fonti R; Camera L; Salvatore B; Faggiano A; Ciarmiello A; Segreto S; Colao A; Salvatore M; Del Vecchio S
    Ann Nucl Med; 2016 Apr; 30(3):234-41. PubMed ID: 26753628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Study Comparing
    Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
    J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer: role of SPECT and PET in imaging bone metastases.
    Beheshti M; Langsteger W; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):396-407. PubMed ID: 19801219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hybrid SPECT-CT in oncology: current and emerging clinical applications.
    Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2008 Mar; 63(3):241-51. PubMed ID: 18275863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.
    Homann G; Mustafa DF; Ditt H; Spengler W; Kopp HG; Nikolaou K; Horger M
    Acad Radiol; 2015 Apr; 22(4):505-12. PubMed ID: 25586709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ¹⁸F-fluoride PET/CT, ¹⁸F-FDG PET/CT and bone scintigraphy (planar and SPECT) in detection of bone metastases of differentiated thyroid cancer: a pilot study.
    Ota N; Kato K; Iwano S; Ito S; Abe S; Fujita N; Yamashiro K; Yamamoto S; Naganawa S
    Br J Radiol; 2014 Feb; 87(1034):20130444. PubMed ID: 24297809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2005; 25(6C):4439-44. PubMed ID: 16334123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.